Tarsus Pharmaceuticals Inc (NASDAQ: TARS) is a pharmaceutical company that develops and commercializes prescription treatments. The filing excerpts available from the 10-K filed 2026-02-23 (accession 000181979026000019) do not provide sufficient detail to describe the company's specific products, revenue figures, business segments, or competitive position. The cover page confirms the company is listed on the Nasdaq Global Market under the ticker TARS, but the substantive business description, financial results, and operating details are not present in the provided excerpts. No further factual claims about revenue model, customers, geography, or competitors can be supported from the available filing text.

Source: SEC 10-K, filed 2026-02-23

Industry: Biological Products, (No Diagnostic Substances) Peers: Bakhu Holdings, Corp. Tvardi Therapeutics Inc Esperion Therapeutics Inc Evolus Inc Fulcrum Therapeutics Inc Ocular Therapeutix Inc Johnson & Johnson Nuvation Bio Inc Phathom Pharmaceuticals Inc Rani Therapeutics Holdings Inc